Jincheng Pharmaceutical: Nicotine Project Has Annual Capacity of 200 Tons, No Direct Business Ties w

Jincheng Pharmaceutical, a company listed on the Shenzhen Stock Exchange, stated on an investor Q&A platform that its synthetic nicotine can be exported and that the company holds the relevant export qualifications. The company’s nicotine project has a production capacity of 200 tons per year and is currently undergoing technical upgrades.

[Two Supreme Flash News] On August 24, Jincheng Pharmaceutical, a Shenzhen Stock Exchange-listed company, stated on an investor Q&A platform that its synthetic nicotine can be exported and that the company has the relevant export qualifications. The nicotine project has a production capacity of 200 tons per year and is currently undergoing technical upgrades.

The company also said it is very optimistic about the vaping sector. On one hand, it plans to expand its nicotine business horizontally by leveraging its nicotine extraction platform to develop flavoring products. On the other hand, it will actively seek opportunities to expand downstream, fully utilizing the value advantages of its upstream nicotine business to build itself into a leading nicotine enterprise. In 2023, its wholly owned subsidiary Jincheng Medical Chemical newly obtained export qualifications for nicotine used in vaping products, and its production scale has been further expanded, which is of positive significance for the company in expanding domestic and overseas markets and serving downstream customers.

At the same time, when asked whether it supplies SKE, the company said its customers are downstream e-liquid companies in the vaping industry, while SKE is not an e-liquid manufacturer.

Q&A page | Image source: Hudongyi

Q&A page | Image source: Hudongyi

Q&A page | Image source: Hudongyi

References:

[1] Q&A platform details

[2] Q&A platform details